PubMed, Esposito, Gianluca, et al
It is currently indicated for use in adults with obesity (with a BMI of 30 kg/m2 or greater) or overweight adults (with a BMI of 27 kg/m2 or greater) who also have weight-related medical problems such as type 2 diabetes, high blood pressure, obstructive sleep apnea, or cardiovascular disease
We assess your hormone levels, health history, and specific goals before recommending a sermorelin therapy or CJC-1295 protocol
Table of contents Choosing the best peptide company in 2026 means cutting through a fast-changing legal picture
Great product, easy to order and great customer service
lipotropic injections are not appropriate for everyone